Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women

Lytt I. Gardner, Scott D. Holmberg, John M. Williamson, Lynda A. Szczech, Charles C J Carpenter, Anne Marie Rompalo, Paula Schuman, Robert S. Klein

Research output: Contribution to journalArticle

Abstract

Background: Data on the incidence and prognostic significance of renal dysfunction in HIV disease are limited. Objective: To determine the incidence of proteinuria and elevated serum creatinine in HIV-positive and HIV-negative women and to determine whether these abnormalities are predictors of mortality or associated with causes of death listed on the death certificate in HIV-positive women. Design: The incidence of proteinuria or elevated serum creatinine and mortality was assessed in a cohort of 885 HIV-positive women and 425 at-risk HIV-negative women. Setting: Women from the general community or HIV care clinics in four urban locations in the United States. Outcome Measures: Creatinine of ≥ 1.4 mg/dL, proteinuria 2+ or more, or both. Deaths confirmed by a death certificate (92%) or medical record/community report (8%). Results: At baseline, 64 (7.2%) HIV-positive women and 10 (2.4%) HIV-negative women had proteinuria or elevated creatinine. An additional 128 (14%) HIV-positive women and 18 (4%) HIV-negative women developed these abnormalities over the next (mean) 21 months. Relative hazards of mortality were significantly increased (adjusted relative hazard = 2.5; 95% confidence interval: 1.9-3.3), and there were more renal causes recorded on death certificates (24/92 (26%) vs. 3/127 (2.7%), p <.0001) in HIV-infected women with, compared with those without these renal abnormalities. Conclusions: Proteinuria, elevated serum creatinine, or both frequently occurred in these HIV-infected women. These renal abnormalities in HIV-infected women are associated with an increased risk of death after controlling for other risk factors and with an increased likelihood of having renal causes listed on the death certificate. The recognition and management of proteinuria and elevated serum creatinine should be a priority for HIV-infected persons.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume32
Issue number2
StatePublished - Feb 2003

Fingerprint

Proteinuria
Creatinine
HIV
Mortality
Serum
Death Certificates
Kidney
Incidence
Medical Records
Cause of Death

Keywords

  • Associated renal abnormalities
  • HIV
  • HIV and women
  • HIV epidemiology
  • HIV-associated nephropathy

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Gardner, L. I., Holmberg, S. D., Williamson, J. M., Szczech, L. A., Carpenter, C. C. J., Rompalo, A. M., ... Klein, R. S. (2003). Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 32(2), 203-209.

Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. / Gardner, Lytt I.; Holmberg, Scott D.; Williamson, John M.; Szczech, Lynda A.; Carpenter, Charles C J; Rompalo, Anne Marie; Schuman, Paula; Klein, Robert S.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 32, No. 2, 02.2003, p. 203-209.

Research output: Contribution to journalArticle

Gardner, LI, Holmberg, SD, Williamson, JM, Szczech, LA, Carpenter, CCJ, Rompalo, AM, Schuman, P & Klein, RS 2003, 'Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women', Journal of Acquired Immune Deficiency Syndromes, vol. 32, no. 2, pp. 203-209.
Gardner LI, Holmberg SD, Williamson JM, Szczech LA, Carpenter CCJ, Rompalo AM et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. Journal of Acquired Immune Deficiency Syndromes. 2003 Feb;32(2):203-209.
Gardner, Lytt I. ; Holmberg, Scott D. ; Williamson, John M. ; Szczech, Lynda A. ; Carpenter, Charles C J ; Rompalo, Anne Marie ; Schuman, Paula ; Klein, Robert S. / Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. In: Journal of Acquired Immune Deficiency Syndromes. 2003 ; Vol. 32, No. 2. pp. 203-209.
@article{7feef9981b3647c9b5bfc87dbf20de7a,
title = "Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women",
abstract = "Background: Data on the incidence and prognostic significance of renal dysfunction in HIV disease are limited. Objective: To determine the incidence of proteinuria and elevated serum creatinine in HIV-positive and HIV-negative women and to determine whether these abnormalities are predictors of mortality or associated with causes of death listed on the death certificate in HIV-positive women. Design: The incidence of proteinuria or elevated serum creatinine and mortality was assessed in a cohort of 885 HIV-positive women and 425 at-risk HIV-negative women. Setting: Women from the general community or HIV care clinics in four urban locations in the United States. Outcome Measures: Creatinine of ≥ 1.4 mg/dL, proteinuria 2+ or more, or both. Deaths confirmed by a death certificate (92{\%}) or medical record/community report (8{\%}). Results: At baseline, 64 (7.2{\%}) HIV-positive women and 10 (2.4{\%}) HIV-negative women had proteinuria or elevated creatinine. An additional 128 (14{\%}) HIV-positive women and 18 (4{\%}) HIV-negative women developed these abnormalities over the next (mean) 21 months. Relative hazards of mortality were significantly increased (adjusted relative hazard = 2.5; 95{\%} confidence interval: 1.9-3.3), and there were more renal causes recorded on death certificates (24/92 (26{\%}) vs. 3/127 (2.7{\%}), p <.0001) in HIV-infected women with, compared with those without these renal abnormalities. Conclusions: Proteinuria, elevated serum creatinine, or both frequently occurred in these HIV-infected women. These renal abnormalities in HIV-infected women are associated with an increased risk of death after controlling for other risk factors and with an increased likelihood of having renal causes listed on the death certificate. The recognition and management of proteinuria and elevated serum creatinine should be a priority for HIV-infected persons.",
keywords = "Associated renal abnormalities, HIV, HIV and women, HIV epidemiology, HIV-associated nephropathy",
author = "Gardner, {Lytt I.} and Holmberg, {Scott D.} and Williamson, {John M.} and Szczech, {Lynda A.} and Carpenter, {Charles C J} and Rompalo, {Anne Marie} and Paula Schuman and Klein, {Robert S.}",
year = "2003",
month = "2",
language = "English (US)",
volume = "32",
pages = "203--209",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women

AU - Gardner, Lytt I.

AU - Holmberg, Scott D.

AU - Williamson, John M.

AU - Szczech, Lynda A.

AU - Carpenter, Charles C J

AU - Rompalo, Anne Marie

AU - Schuman, Paula

AU - Klein, Robert S.

PY - 2003/2

Y1 - 2003/2

N2 - Background: Data on the incidence and prognostic significance of renal dysfunction in HIV disease are limited. Objective: To determine the incidence of proteinuria and elevated serum creatinine in HIV-positive and HIV-negative women and to determine whether these abnormalities are predictors of mortality or associated with causes of death listed on the death certificate in HIV-positive women. Design: The incidence of proteinuria or elevated serum creatinine and mortality was assessed in a cohort of 885 HIV-positive women and 425 at-risk HIV-negative women. Setting: Women from the general community or HIV care clinics in four urban locations in the United States. Outcome Measures: Creatinine of ≥ 1.4 mg/dL, proteinuria 2+ or more, or both. Deaths confirmed by a death certificate (92%) or medical record/community report (8%). Results: At baseline, 64 (7.2%) HIV-positive women and 10 (2.4%) HIV-negative women had proteinuria or elevated creatinine. An additional 128 (14%) HIV-positive women and 18 (4%) HIV-negative women developed these abnormalities over the next (mean) 21 months. Relative hazards of mortality were significantly increased (adjusted relative hazard = 2.5; 95% confidence interval: 1.9-3.3), and there were more renal causes recorded on death certificates (24/92 (26%) vs. 3/127 (2.7%), p <.0001) in HIV-infected women with, compared with those without these renal abnormalities. Conclusions: Proteinuria, elevated serum creatinine, or both frequently occurred in these HIV-infected women. These renal abnormalities in HIV-infected women are associated with an increased risk of death after controlling for other risk factors and with an increased likelihood of having renal causes listed on the death certificate. The recognition and management of proteinuria and elevated serum creatinine should be a priority for HIV-infected persons.

AB - Background: Data on the incidence and prognostic significance of renal dysfunction in HIV disease are limited. Objective: To determine the incidence of proteinuria and elevated serum creatinine in HIV-positive and HIV-negative women and to determine whether these abnormalities are predictors of mortality or associated with causes of death listed on the death certificate in HIV-positive women. Design: The incidence of proteinuria or elevated serum creatinine and mortality was assessed in a cohort of 885 HIV-positive women and 425 at-risk HIV-negative women. Setting: Women from the general community or HIV care clinics in four urban locations in the United States. Outcome Measures: Creatinine of ≥ 1.4 mg/dL, proteinuria 2+ or more, or both. Deaths confirmed by a death certificate (92%) or medical record/community report (8%). Results: At baseline, 64 (7.2%) HIV-positive women and 10 (2.4%) HIV-negative women had proteinuria or elevated creatinine. An additional 128 (14%) HIV-positive women and 18 (4%) HIV-negative women developed these abnormalities over the next (mean) 21 months. Relative hazards of mortality were significantly increased (adjusted relative hazard = 2.5; 95% confidence interval: 1.9-3.3), and there were more renal causes recorded on death certificates (24/92 (26%) vs. 3/127 (2.7%), p <.0001) in HIV-infected women with, compared with those without these renal abnormalities. Conclusions: Proteinuria, elevated serum creatinine, or both frequently occurred in these HIV-infected women. These renal abnormalities in HIV-infected women are associated with an increased risk of death after controlling for other risk factors and with an increased likelihood of having renal causes listed on the death certificate. The recognition and management of proteinuria and elevated serum creatinine should be a priority for HIV-infected persons.

KW - Associated renal abnormalities

KW - HIV

KW - HIV and women

KW - HIV epidemiology

KW - HIV-associated nephropathy

UR - http://www.scopus.com/inward/record.url?scp=0037321542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037321542&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 203

EP - 209

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 2

ER -